From the beta amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease
From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease The latest, on-demand Digital Dialogue from the Lab of the Future features world-renowned presenters with a case study of the application of AI to drive ground-breaking science. Register to attend Dr. Rudolph Tanzi is, inter alia, Vice-Chair of Neurology... Read more →
